-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network News, June 18, June 17, the Chinese government website "Notice of the General Office of the State Council on Printing and Distributing Key Tasks for Deepening the Reform of the Medical and Health System in 2021" (referred to as the "Notice"), focusing on implementing the decisions of the Party Central Committee and the State Council Deployment, in-depth implementation of the Healthy China strategy, promotion of the medical reform experience of Sanming City, strengthening the linkage of the reform system, promoting the balanced distribution of high-quality medical resources, and making arrangements for the key tasks of deepening the reform of the medical and health system in 2021
.
.
The "Notice" puts forward the specific work of 4.
20, and made key arrangements for the medical and health system reform goals such as promoting Sanming's medical reform experience, improving the hierarchical diagnosis and treatment system, strengthening the construction of the public health system, and coordinating and promoting relevant key reforms
.
20, and made key arrangements for the medical and health system reform goals such as promoting Sanming's medical reform experience, improving the hierarchical diagnosis and treatment system, strengthening the construction of the public health system, and coordinating and promoting relevant key reforms
.
Normalization and institutionalization of centralized drug procurement
Since the implementation of the new round of medical and health system reforms, China’s basic medical and health system has been improved rapidly, and the people’s health status and the fairness and accessibility of basic medical and health services have continued to improve
.
Continuing to focus on the transformation from the focus on treating diseases to the focus on people's health, and focusing on solving the problems of difficult and expensive medical care, is undoubtedly the focus of the reform of the medical and health system in the new era
.
.
Continuing to focus on the transformation from the focus on treating diseases to the focus on people's health, and focusing on solving the problems of difficult and expensive medical care, is undoubtedly the focus of the reform of the medical and health system in the new era
.
On May 26, the website of the National Health Commission released "Deputy Director Li Bin went to Sanming City, Fujian Province to investigate and deepen the reform of the medical and health system" and "The Secretariat of the State Council’s Medical Reform Leading Group held an on-site meeting and training class to promote Sanming’s medical reform experience", all of which mentioned Further strengthen the "three-medicine linkage" work, and deepen comprehensive reforms such as price cuts for medicines and consumables, price adjustments for services, medical insurance payments, salary distribution, and medical supervision
.
.
It can be seen that the continuous deepening of the "three-medicine linkage" work, with the reduction of the price of pharmaceutical consumables as a starting point, has been unstoppable to reconstruct the market value chain of the pharmaceutical industry
.
In the "Notice" issued this time, it is clearly proposed to vigorously promote the medical reform experience of Sanming City and promote the related measures of centralized procurement of pharmaceutical consumables:
.
In the "Notice" issued this time, it is clearly proposed to vigorously promote the medical reform experience of Sanming City and promote the related measures of centralized procurement of pharmaceutical consumables:
(1) Vigorously promote the medical reform experience of Sanming City
.
Build a national experience promotion base for deepening medical reform in Sanming City, and increase experience promotion efforts
.
In accordance with the path of "making space, adjusting structure, and ensuring connectivity", with the price reduction as a breakthrough point, comprehensive reforms such as medical service prices, salaries, and medical insurance payments will be promoted simultaneously
.
Improve the service system and institutional mechanisms to promote the balanced distribution of high-quality medical resources
.
Strengthen the guidance to promote the medical reform experience of Sanming City
.
(The Secretariat of the Medical Reform Leading Group of the State Council and relevant departments are responsible according to the division of responsibilities)
.
Build a national experience promotion base for deepening medical reform in Sanming City, and increase experience promotion efforts
.
In accordance with the path of "making space, adjusting structure, and ensuring connectivity", with the price reduction as a breakthrough point, comprehensive reforms such as medical service prices, salaries, and medical insurance payments will be promoted simultaneously
.
Improve the service system and institutional mechanisms to promote the balanced distribution of high-quality medical resources
.
Strengthen the guidance to promote the medical reform experience of Sanming City
.
(The Secretariat of the Medical Reform Leading Group of the State Council and relevant departments are responsible according to the division of responsibilities)
(2) Promote centralized procurement of pharmaceuticals and consumables
.
Normalize and institutionalize the centralized procurement of drugs organized by the state, and gradually expand the scope of centralized procurement of drugs and high-value medical consumables
.
Implement the national organization policy of centralizing the procurement of medical insurance funds for pharmaceuticals and consumables, guide medical institutions to make good use of the increased disposable income, and actively promote the reform of the salary system
.
Intensify efforts to promote the use of drugs under the national medical insurance negotiations, and further improve relevant policies and measures by the end of August 2021
.
Establish and implement a credit evaluation system for medical prices and recruitment and procurement
.
Promote uniform classification and coding standards for medical insurance drugs and medical consumables
.
Promote the application of the unique identification of medical devices in the fields of supervision, medical treatment, and medical insurance
.
(The National Medical Insurance Bureau, the National Health Commission, the Ministry of Finance, the Ministry of Human Resources and Social Security, the State Drug Administration, etc.
are responsible according to the division of responsibilities)
.
Normalize and institutionalize the centralized procurement of drugs organized by the state, and gradually expand the scope of centralized procurement of drugs and high-value medical consumables
.
Implement the national organization policy of centralizing the procurement of medical insurance funds for pharmaceuticals and consumables, guide medical institutions to make good use of the increased disposable income, and actively promote the reform of the salary system
.
Intensify efforts to promote the use of drugs under the national medical insurance negotiations, and further improve relevant policies and measures by the end of August 2021
.
Establish and implement a credit evaluation system for medical prices and recruitment and procurement
.
Promote uniform classification and coding standards for medical insurance drugs and medical consumables
.
Promote the application of the unique identification of medical devices in the fields of supervision, medical treatment, and medical insurance
.
(The National Medical Insurance Bureau, the National Health Commission, the Ministry of Finance, the Ministry of Human Resources and Social Security, the State Drug Administration, etc.
are responsible according to the division of responsibilities)
Taking the price of medicines as the starting point, medical insurance is leading the deepening of medical reform through "small cuts and big reforms"
.
Hu Jinglin, Secretary of the Party Leadership Group and Director of the National Medical Security Administration, pointed out in an earlier article that to overcome difficulties, find a fulcrum, and gradually normalize centralized procurement, effectively squeeze the water consumption of medicines, reduce the burden on the masses, purify the ecology of the industry, and standardize medical behaviors.
Three batches of countries Organized the centralized procurement of medicines covering 112 varieties, with an average price reduction of 54%, saving 53.
9 billion yuan in annual costs; for the first time the state organized the centralized procurement of high-value medical consumables, the price of selected coronary stents dropped by more than 90%, and it is estimated that annual medical costs will be saved by 11.
7 billion yuan.
.
.
Hu Jinglin, Secretary of the Party Leadership Group and Director of the National Medical Security Administration, pointed out in an earlier article that to overcome difficulties, find a fulcrum, and gradually normalize centralized procurement, effectively squeeze the water consumption of medicines, reduce the burden on the masses, purify the ecology of the industry, and standardize medical behaviors.
Three batches of countries Organized the centralized procurement of medicines covering 112 varieties, with an average price reduction of 54%, saving 53.
9 billion yuan in annual costs; for the first time the state organized the centralized procurement of high-value medical consumables, the price of selected coronary stents dropped by more than 90%, and it is estimated that annual medical costs will be saved by 11.
7 billion yuan.
.
The industry generally believes that the normalized and institutionalized state-organized centralized drug procurement is bound to further reduce the price space of generic drugs and products with high clinical substitutability, and at the same time "free the cage and change the bird" for high clinical value drugs, and the direction of the medical and health system reform The will of the country has been fully demonstrated, the "three-medicine linkage" has been intensified, the compliance supervision of the pharmaceutical market has been strengthened, and the policy scope has been expanded to hospitals and hospitals.
The profit and category of the channel market will encounter a huge impact
.
The profit and category of the channel market will encounter a huge impact
.
Support the development of the grassroots Chinese medicine market
Insist on giving full play to the unique advantages and diversified value of traditional Chinese medicine, insisting on highlighting the core value of traditional Chinese medicine medical services, helping a healthy China, and promoting the revitalization and development of traditional Chinese medicine.
Once again, the top policy support of the State Council:
Once again, the top policy support of the State Council:
(11) Promote the revitalization and development of Chinese medicine
.
Implement major projects for the revitalization and development of traditional Chinese medicine
.
Support the creation of a number of national traditional Chinese medicine inheritance and innovation centers, traditional Chinese and Western medicine collaboration "flagship" hospitals , key hospitals with traditional Chinese medicine characteristics, and national Chinese medicine epidemic prevention and control bases, and implement the famous doctor hall project to improve the infectious disease prevention and control capabilities of county-level Chinese medicine hospitals
.
Promote Chinese medicine hospitals to take the lead in forming medical consortia
.
Improve in line with traditional Chinese medicine Medicare payment policy features, release TCM dominant diseases
.
Promote the construction of a national comprehensive reform demonstration zone for traditional Chinese medicine
.
Before the end of September 2021, develop and implement opinions on promoting the upgrading of the TCM treatment of disease-free health projects
.
(State Administration of Traditional Chinese Medicine, National Development and Reform Commission, National Health Commission, National Medical Insurance Bureau, etc.
are responsible according to the division of responsibilities)
.
Implement major projects for the revitalization and development of traditional Chinese medicine
.
Support the creation of a number of national traditional Chinese medicine inheritance and innovation centers, traditional Chinese and Western medicine collaboration "flagship" hospitals , key hospitals with traditional Chinese medicine characteristics, and national Chinese medicine epidemic prevention and control bases, and implement the famous doctor hall project to improve the infectious disease prevention and control capabilities of county-level Chinese medicine hospitals
.
Promote Chinese medicine hospitals to take the lead in forming medical consortia
.
Improve in line with traditional Chinese medicine Medicare payment policy features, release TCM dominant diseases
.
Promote the construction of a national comprehensive reform demonstration zone for traditional Chinese medicine
.
Before the end of September 2021, develop and implement opinions on promoting the upgrading of the TCM treatment of disease-free health projects
.
(State Administration of Traditional Chinese Medicine, National Development and Reform Commission, National Health Commission, National Medical Insurance Bureau, etc.
are responsible according to the division of responsibilities)
In fact, promote the revitalization and development of traditional Chinese medicine, comprehensively improve the characteristic advantages and service capabilities of traditional Chinese medicine, meet the people's demand for traditional Chinese medicine, and focus on major chronic diseases such as cardiovascular diseases, neurological diseases, malignant tumors, metabolic diseases, and gynecology, Dominant diseases such as skin and immunity, and dominance diseases of traditional Chinese medicine such as acupuncture and other non-drug therapies have become important directions for the development of Chinese medicine during the 14th Five-Year Plan
.
.
In addition, vigorously strengthening the construction of the grassroots TCM talent team can consolidate the foundation of TCM development
.
The analysis of industry experts pointed out that the total number of TCM professionals is insufficient and the gap is large, especially for high-quality, compound and general-care personnel.
It is necessary to do a good job in the mid- and long-term planning of talent training and team building, and improve the basic level of TCM teachers.
Education and training mechanisms, rationally increase the special funding for grassroots Chinese medicine, formulate preferential policies for the introduction of talents, improve the working environment of grassroots Chinese medicine personnel, and improve the size and overall quality of the grassroots Chinese medicine talent team through various means
.
.
The analysis of industry experts pointed out that the total number of TCM professionals is insufficient and the gap is large, especially for high-quality, compound and general-care personnel.
It is necessary to do a good job in the mid- and long-term planning of talent training and team building, and improve the basic level of TCM teachers.
Education and training mechanisms, rationally increase the special funding for grassroots Chinese medicine, formulate preferential policies for the introduction of talents, improve the working environment of grassroots Chinese medicine personnel, and improve the size and overall quality of the grassroots Chinese medicine talent team through various means
.
It is understood that in the review and approval of traditional Chinese medicine and drug research and development, the State Drug Administration is cooperating with the State Drug Administration approval of the reform continue to improve the review of Chinese medicine, Chinese medicine industry to promote the development of new drug development and medicine
.
Adhere to the clinical value as the orientation, promote the establishment of efficacy evaluation standards that are compatible with the clinical positioning of traditional Chinese medicine and reflect its features and advantages, and encourage patient-centered efficacy evaluation
.
Promote the development of ancient classic famous prescriptions and traditional Chinese medicine compound preparations, organize research and formulate key information research opinions on ancient classic famous prescriptions, establish a review model compatible with the characteristics of ancient classic famous prescriptions and traditional Chinese medicine compound preparations, and simplify approval procedures
.
.
Adhere to the clinical value as the orientation, promote the establishment of efficacy evaluation standards that are compatible with the clinical positioning of traditional Chinese medicine and reflect its features and advantages, and encourage patient-centered efficacy evaluation
.
Promote the development of ancient classic famous prescriptions and traditional Chinese medicine compound preparations, organize research and formulate key information research opinions on ancient classic famous prescriptions, establish a review model compatible with the characteristics of ancient classic famous prescriptions and traditional Chinese medicine compound preparations, and simplify approval procedures
.
Medical Network News, June 18, June 17, the Chinese government website "Notice of the General Office of the State Council on Printing and Distributing Key Tasks for Deepening the Reform of the Medical and Health System in 2021" (referred to as the "Notice"), focusing on implementing the decisions of the Party Central Committee and the State Council Deployment, in-depth implementation of the Healthy China strategy, promotion of the medical reform experience of Sanming City, strengthening the linkage of the reform system, promoting the balanced distribution of high-quality medical resources, and making arrangements for the key tasks of deepening the reform of the medical and health system in 2021
.
.
The "Notice" puts forward the specific work of 4.
20, and made key arrangements for the medical and health system reform goals such as promoting Sanming's medical reform experience, improving the hierarchical diagnosis and treatment system, strengthening the construction of the public health system, and coordinating and promoting relevant key reforms
.
20, and made key arrangements for the medical and health system reform goals such as promoting Sanming's medical reform experience, improving the hierarchical diagnosis and treatment system, strengthening the construction of the public health system, and coordinating and promoting relevant key reforms
.
Normalization and institutionalization of centralized drug procurement
Since the implementation of the new round of medical and health system reforms, China’s basic medical and health system has been improved rapidly, and the people’s health status and the fairness and accessibility of basic medical and health services have continued to improve
.
Continuing to focus on the transformation from the focus on treating diseases to the focus on people's health, and focusing on solving the problems of difficult and expensive medical care, is undoubtedly the focus of the reform of the medical and health system in the new era
.
.
Continuing to focus on the transformation from the focus on treating diseases to the focus on people's health, and focusing on solving the problems of difficult and expensive medical care, is undoubtedly the focus of the reform of the medical and health system in the new era
.
On May 26, the website of the National Health Commission released "Deputy Director Li Bin went to Sanming City, Fujian Province to investigate and deepen the reform of the medical and health system" and "The Secretariat of the State Council’s Medical Reform Leading Group held an on-site meeting and training class to promote Sanming’s medical reform experience", all of which mentioned Further strengthen the "three-medicine linkage" work, and deepen comprehensive reforms such as price cuts for medicines and consumables, price adjustments for services, medical insurance payments, salary distribution, and medical supervision
.
.
It can be seen that the continuous deepening of the "three-medicine linkage" work, with the reduction of the price of pharmaceutical consumables as a starting point, has been unstoppable to reconstruct the market value chain of the pharmaceutical industry
.
In the "Notice" issued this time, it is clearly proposed to vigorously promote the medical reform experience of Sanming City and promote the related measures of centralized procurement of pharmaceutical consumables:
.
In the "Notice" issued this time, it is clearly proposed to vigorously promote the medical reform experience of Sanming City and promote the related measures of centralized procurement of pharmaceutical consumables:
(1) Vigorously promote the medical reform experience of Sanming City
.
Build a national experience promotion base for deepening medical reform in Sanming City, and increase experience promotion efforts
.
In accordance with the path of "making space, adjusting structure, and ensuring connectivity", with the price reduction as a breakthrough point, comprehensive reforms such as medical service prices, salaries, and medical insurance payments will be promoted simultaneously
.
Improve the service system and institutional mechanisms to promote the balanced distribution of high-quality medical resources
.
Strengthen the guidance to promote the medical reform experience of Sanming City
.
(The Secretariat of the Medical Reform Leading Group of the State Council and relevant departments are responsible according to the division of responsibilities)
.
Build a national experience promotion base for deepening medical reform in Sanming City, and increase experience promotion efforts
.
In accordance with the path of "making space, adjusting structure, and ensuring connectivity", with the price reduction as a breakthrough point, comprehensive reforms such as medical service prices, salaries, and medical insurance payments will be promoted simultaneously
.
Improve the service system and institutional mechanisms to promote the balanced distribution of high-quality medical resources
.
Strengthen the guidance to promote the medical reform experience of Sanming City
.
(The Secretariat of the Medical Reform Leading Group of the State Council and relevant departments are responsible according to the division of responsibilities)
(2) Promote centralized procurement of pharmaceuticals and consumables
.
Normalize and institutionalize the centralized procurement of drugs organized by the state, and gradually expand the scope of centralized procurement of drugs and high-value medical consumables
.
Implement the national organization policy of centralizing the procurement of medical insurance funds for pharmaceuticals and consumables, guide medical institutions to make good use of the increased disposable income, and actively promote the reform of the salary system
.
Intensify efforts to promote the use of drugs under the national medical insurance negotiations, and further improve relevant policies and measures by the end of August 2021
.
Establish and implement a credit evaluation system for medical prices and recruitment and procurement
.
Promote uniform classification and coding standards for medical insurance drugs and medical consumables
.
Promote the application of the unique identification of medical devices in the fields of supervision, medical treatment, and medical insurance
.
(The National Medical Insurance Bureau, the National Health Commission, the Ministry of Finance, the Ministry of Human Resources and Social Security, the State Drug Administration, etc.
are responsible according to the division of responsibilities)
.
Normalize and institutionalize the centralized procurement of drugs organized by the state, and gradually expand the scope of centralized procurement of drugs and high-value medical consumables
.
Implement the national organization policy of centralizing the procurement of medical insurance funds for pharmaceuticals and consumables, guide medical institutions to make good use of the increased disposable income, and actively promote the reform of the salary system
.
Intensify efforts to promote the use of drugs under the national medical insurance negotiations, and further improve relevant policies and measures by the end of August 2021
.
Establish and implement a credit evaluation system for medical prices and recruitment and procurement
.
Promote uniform classification and coding standards for medical insurance drugs and medical consumables
.
Promote the application of the unique identification of medical devices in the fields of supervision, medical treatment, and medical insurance
.
(The National Medical Insurance Bureau, the National Health Commission, the Ministry of Finance, the Ministry of Human Resources and Social Security, the State Drug Administration, etc.
are responsible according to the division of responsibilities)
Taking the price of medicines as the starting point, medical insurance is leading the deepening of medical reform through "small cuts and big reforms"
.
Hu Jinglin, Secretary of the Party Leadership Group and Director of the National Medical Security Administration, pointed out in an earlier article that to overcome difficulties, find a fulcrum, and gradually normalize centralized procurement, effectively squeeze the water consumption of medicines, reduce the burden on the masses, purify the ecology of the industry, and standardize medical behaviors.
Three batches of countries Organized the centralized procurement of medicines covering 112 varieties, with an average price reduction of 54%, saving 53.
9 billion yuan in annual costs; for the first time the state organized the centralized procurement of high-value medical consumables, the price of selected coronary stents dropped by more than 90%, and it is estimated that annual medical costs will be saved by 11.
7 billion yuan.
.
.
Hu Jinglin, Secretary of the Party Leadership Group and Director of the National Medical Security Administration, pointed out in an earlier article that to overcome difficulties, find a fulcrum, and gradually normalize centralized procurement, effectively squeeze the water consumption of medicines, reduce the burden on the masses, purify the ecology of the industry, and standardize medical behaviors.
Three batches of countries Organized the centralized procurement of medicines covering 112 varieties, with an average price reduction of 54%, saving 53.
9 billion yuan in annual costs; for the first time the state organized the centralized procurement of high-value medical consumables, the price of selected coronary stents dropped by more than 90%, and it is estimated that annual medical costs will be saved by 11.
7 billion yuan.
.
The industry generally believes that the normalized and institutionalized state-organized centralized drug procurement is bound to further reduce the price space of generic drugs and products with high clinical substitutability, and at the same time "free the cage and change the bird" for high clinical value drugs, and the direction of the medical and health system reform The will of the country has been fully demonstrated, the "three-medicine linkage" has been intensified, the compliance supervision of the pharmaceutical market has been strengthened, and the policy scope has been expanded to hospitals and hospitals.
The profit and category of the channel market will encounter a huge impact
.
The profit and category of the channel market will encounter a huge impact
.
Support the development of the grassroots Chinese medicine market
Insist on giving full play to the unique advantages and diversified value of traditional Chinese medicine, insisting on highlighting the core value of traditional Chinese medicine medical services, helping a healthy China, and promoting the revitalization and development of traditional Chinese medicine.
Once again, the top policy support of the State Council:
Once again, the top policy support of the State Council:
(11) Promote the revitalization and development of Chinese medicine
.
Implement major projects for the revitalization and development of traditional Chinese medicine
.
Support the creation of a number of national traditional Chinese medicine inheritance and innovation centers, traditional Chinese and Western medicine collaboration "flagship" hospitals , key hospitals with traditional Chinese medicine characteristics, and national Chinese medicine epidemic prevention and control bases, and implement the famous doctor hall project to improve the infectious disease prevention and control capabilities of county-level Chinese medicine hospitals
.
Promote Chinese medicine hospitals to take the lead in forming medical consortia
.
Improve in line with traditional Chinese medicine Medicare payment policy features, release TCM dominant diseases
.
Promote the construction of a national comprehensive reform demonstration zone for traditional Chinese medicine
.
Before the end of September 2021, develop and implement opinions on promoting the upgrading of the TCM treatment of disease-free health projects
.
(State Administration of Traditional Chinese Medicine, National Development and Reform Commission, National Health Commission, National Medical Insurance Bureau, etc.
are responsible according to the division of responsibilities)
.
Implement major projects for the revitalization and development of traditional Chinese medicine
.
Support the creation of a number of national traditional Chinese medicine inheritance and innovation centers, traditional Chinese and Western medicine collaboration "flagship" hospitals , key hospitals with traditional Chinese medicine characteristics, and national Chinese medicine epidemic prevention and control bases, and implement the famous doctor hall project to improve the infectious disease prevention and control capabilities of county-level Chinese medicine hospitals
.
Promote Chinese medicine hospitals to take the lead in forming medical consortia
.
Improve in line with traditional Chinese medicine Medicare payment policy features, release TCM dominant diseases
.
Promote the construction of a national comprehensive reform demonstration zone for traditional Chinese medicine
.
Before the end of September 2021, develop and implement opinions on promoting the upgrading of the TCM treatment of disease-free health projects
.
(State Administration of Traditional Chinese Medicine, National Development and Reform Commission, National Health Commission, National Medical Insurance Bureau, etc.
are responsible according to the division of responsibilities)
In fact, promote the revitalization and development of traditional Chinese medicine, comprehensively improve the characteristic advantages and service capabilities of traditional Chinese medicine, meet the people's demand for traditional Chinese medicine, and focus on major chronic diseases such as cardiovascular diseases, neurological diseases, malignant tumors, metabolic diseases, and gynecology, Dominant diseases such as skin and immunity, and dominance diseases of traditional Chinese medicine such as acupuncture and other non-drug therapies have become important directions for the development of Chinese medicine during the 14th Five-Year Plan
.
.
In addition, vigorously strengthening the construction of the grassroots TCM talent team can consolidate the foundation of TCM development
.
The analysis of industry experts pointed out that the total number of TCM professionals is insufficient and the gap is large, especially for high-quality, compound and general-care personnel.
It is necessary to do a good job in the mid- and long-term planning of talent training and team building, and improve the basic level of TCM teachers.
Education and training mechanisms, rationally increase the special funding for grassroots Chinese medicine, formulate preferential policies for the introduction of talents, improve the working environment of grassroots Chinese medicine personnel, and improve the size and overall quality of the grassroots Chinese medicine talent team through various means
.
.
The analysis of industry experts pointed out that the total number of TCM professionals is insufficient and the gap is large, especially for high-quality, compound and general-care personnel.
It is necessary to do a good job in the mid- and long-term planning of talent training and team building, and improve the basic level of TCM teachers.
Education and training mechanisms, rationally increase the special funding for grassroots Chinese medicine, formulate preferential policies for the introduction of talents, improve the working environment of grassroots Chinese medicine personnel, and improve the size and overall quality of the grassroots Chinese medicine talent team through various means
.
It is understood that in the review and approval of traditional Chinese medicine and drug research and development, the State Drug Administration is cooperating with the State Drug Administration approval of the reform continue to improve the review of Chinese medicine, Chinese medicine industry to promote the development of new drug development and medicine
.
Adhere to the clinical value as the orientation, promote the establishment of efficacy evaluation standards that are compatible with the clinical positioning of traditional Chinese medicine and reflect its features and advantages, and encourage patient-centered efficacy evaluation
.
Promote the development of ancient classic famous prescriptions and traditional Chinese medicine compound preparations, organize research and formulate key information research opinions on ancient classic famous prescriptions, establish a review model compatible with the characteristics of ancient classic famous prescriptions and traditional Chinese medicine compound preparations, and simplify approval procedures
.
.
Adhere to the clinical value as the orientation, promote the establishment of efficacy evaluation standards that are compatible with the clinical positioning of traditional Chinese medicine and reflect its features and advantages, and encourage patient-centered efficacy evaluation
.
Promote the development of ancient classic famous prescriptions and traditional Chinese medicine compound preparations, organize research and formulate key information research opinions on ancient classic famous prescriptions, establish a review model compatible with the characteristics of ancient classic famous prescriptions and traditional Chinese medicine compound preparations, and simplify approval procedures
.
Medical Network News, June 18, June 17, the Chinese government website "Notice of the General Office of the State Council on Printing and Distributing Key Tasks for Deepening the Reform of the Medical and Health System in 2021" (referred to as the "Notice"), focusing on implementing the decisions of the Party Central Committee and the State Council Deployment, in-depth implementation of the Healthy China strategy, promotion of the medical reform experience of Sanming City, strengthening the linkage of the reform system, promoting the balanced distribution of high-quality medical resources, and making arrangements for the key tasks of deepening the reform of the medical and health system in 2021
.
.
The "Notice" puts forward the specific work of 4.
20, and made key arrangements for the medical and health system reform goals such as promoting Sanming's medical reform experience, improving the hierarchical diagnosis and treatment system, strengthening the construction of the public health system, and coordinating and promoting relevant key reforms
.
Medicine Medicine Medicine20, and made key arrangements for the medical and health system reform goals such as promoting Sanming's medical reform experience, improving the hierarchical diagnosis and treatment system, strengthening the construction of the public health system, and coordinating and promoting relevant key reforms
.
Normalization and institutionalization of centralized drug procurement
Normalization and institutionalization of centralized drug procurement Since the implementation of the new round of medical and health system reforms, China’s basic medical and health system has been improved rapidly, and the people’s health status and the fairness and accessibility of basic medical and health services have continued to improve
.
Continuing to focus on the transformation from the focus on treating diseases to the focus on people's health, and focusing on solving the problems of difficult and expensive medical care, is undoubtedly the focus of the reform of the medical and health system in the new era
.
.
Continuing to focus on the transformation from the focus on treating diseases to the focus on people's health, and focusing on solving the problems of difficult and expensive medical care, is undoubtedly the focus of the reform of the medical and health system in the new era
.
On May 26, the website of the National Health Commission released "Deputy Director Li Bin went to Sanming City, Fujian Province to investigate and deepen the reform of the medical and health system" and "The Secretariat of the State Council’s Medical Reform Leading Group held an on-site meeting and training class to promote Sanming’s medical reform experience", all of which mentioned Further strengthen the "three-medicine linkage" work, and deepen comprehensive reforms such as price cuts for medicines and consumables, price adjustments for services, medical insurance payments, salary distribution, and medical supervision
.
.
It can be seen that the continuous deepening of the "three-medicine linkage" work, with the reduction of the price of pharmaceutical consumables as a starting point, has been unstoppable to reconstruct the market value chain of the pharmaceutical industry
.
In the "Notice" issued this time, it is clearly proposed to vigorously promote the medical reform experience of Sanming City and promote the related measures of centralized procurement of pharmaceutical consumables:
.
In the "Notice" issued this time, it is clearly proposed to vigorously promote the medical reform experience of Sanming City and promote the related measures of centralized procurement of pharmaceutical consumables:
(1) Vigorously promote the medical reform experience of Sanming City
.
Build a national experience promotion base for deepening medical reform in Sanming City, and increase experience promotion efforts
.
In accordance with the path of "making space, adjusting structure, and ensuring connectivity", with the price reduction as a breakthrough point, comprehensive reforms such as medical service prices, salaries, and medical insurance payments will be promoted simultaneously
.
Improve the service system and institutional mechanisms to promote the balanced distribution of high-quality medical resources
.
Strengthen the guidance to promote the medical reform experience of Sanming City
.
(The Secretariat of the Medical Reform Leading Group of the State Council and relevant departments are responsible according to the division of responsibilities)
.
Build a national experience promotion base for deepening medical reform in Sanming City, and increase experience promotion efforts
.
In accordance with the path of "making space, adjusting structure, and ensuring connectivity", with the price reduction as a breakthrough point, comprehensive reforms such as medical service prices, salaries, and medical insurance payments will be promoted simultaneously
.
Improve the service system and institutional mechanisms to promote the balanced distribution of high-quality medical resources
.
Strengthen the guidance to promote the medical reform experience of Sanming City
.
(The Secretariat of the Medical Reform Leading Group of the State Council and relevant departments are responsible according to the division of responsibilities)
(2) Promote centralized procurement of pharmaceuticals and consumables
.
Normalize and institutionalize the centralized procurement of drugs organized by the state, and gradually expand the scope of centralized procurement of drugs and high-value medical consumables
.
Implement the national organization policy of centralizing the procurement of medical insurance funds for pharmaceuticals and consumables, guide medical institutions to make good use of the increased disposable income, and actively promote the reform of the salary system
.
Intensify efforts to promote the use of drugs under the national medical insurance negotiations, and further improve relevant policies and measures by the end of August 2021
.
Establish and implement a credit evaluation system for medical prices and recruitment and procurement
.
Promote uniform classification and coding standards for medical insurance drugs and medical consumables
.
Promote the application of the unique identification of medical devices in the fields of supervision, medical treatment, and medical insurance
.
(The National Medical Insurance Bureau, the National Health Commission, the Ministry of Finance, the Ministry of Human Resources and Social Security, the State Drug Administration, etc.
are responsible according to the division of responsibilities)
Medical equipment medical equipment medical equipment.
Normalize and institutionalize the centralized procurement of drugs organized by the state, and gradually expand the scope of centralized procurement of drugs and high-value medical consumables
.
Implement the national organization policy of centralizing the procurement of medical insurance funds for pharmaceuticals and consumables, guide medical institutions to make good use of the increased disposable income, and actively promote the reform of the salary system
.
Intensify efforts to promote the use of drugs under the national medical insurance negotiations, and further improve relevant policies and measures by the end of August 2021
.
Establish and implement a credit evaluation system for medical prices and recruitment and procurement
.
Promote uniform classification and coding standards for medical insurance drugs and medical consumables
.
Promote the application of the unique identification of medical devices in the fields of supervision, medical treatment, and medical insurance
.
(The National Medical Insurance Bureau, the National Health Commission, the Ministry of Finance, the Ministry of Human Resources and Social Security, the State Drug Administration, etc.
are responsible according to the division of responsibilities)
Taking the price of medicines as the starting point, medical insurance is leading the deepening of medical reform through "small cuts and big reforms"
.
Hu Jinglin, Secretary of the Party Leadership Group and Director of the National Medical Security Administration, pointed out in an earlier article that to overcome difficulties, find a fulcrum, and gradually normalize centralized procurement, effectively squeeze the water consumption of medicines, reduce the burden on the masses, purify the ecology of the industry, and standardize medical behaviors.
Three batches of countries Organized the centralized procurement of medicines covering 112 varieties, with an average price reduction of 54%, saving 53.
9 billion yuan in annual costs; for the first time the state organized the centralized procurement of high-value medical consumables, the price of selected coronary stents dropped by more than 90%, and it is estimated that annual medical costs will be saved by 11.
7 billion yuan.
.
.
Hu Jinglin, Secretary of the Party Leadership Group and Director of the National Medical Security Administration, pointed out in an earlier article that to overcome difficulties, find a fulcrum, and gradually normalize centralized procurement, effectively squeeze the water consumption of medicines, reduce the burden on the masses, purify the ecology of the industry, and standardize medical behaviors.
Three batches of countries Organized the centralized procurement of medicines covering 112 varieties, with an average price reduction of 54%, saving 53.
9 billion yuan in annual costs; for the first time the state organized the centralized procurement of high-value medical consumables, the price of selected coronary stents dropped by more than 90%, and it is estimated that annual medical costs will be saved by 11.
7 billion yuan.
.
The industry generally believes that the normalized and institutionalized state-organized centralized drug procurement is bound to further reduce the price space of generic drugs and products with high clinical substitutability, and at the same time "free the cage and change the bird" for high clinical value drugs, and the direction of the medical and health system reform The will of the country has been fully demonstrated, the "three-medicine linkage" has been intensified, the compliance supervision of the pharmaceutical market has been strengthened, and the policy scope has been expanded to hospitals and hospitals.
The profit and category of the channel market will encounter a huge impact
.
The profit and category of the channel market will encounter a huge impact
.
Support the development of the grassroots Chinese medicine market
Support the development of the grassroots Chinese medicine market Insist on giving full play to the unique advantages and diversified value of traditional Chinese medicine, insisting on highlighting the core value of traditional Chinese medicine medical services, helping a healthy China, and promoting the revitalization and development of traditional Chinese medicine.
Once again, the top policy support of the State Council:
Once again, the top policy support of the State Council:
(11) Promote the revitalization and development of Chinese medicine
.
Implement major projects for the revitalization and development of traditional Chinese medicine
.
Support the creation of a number of national traditional Chinese medicine inheritance and innovation centers, traditional Chinese and Western medicine collaboration "flagship" hospitals , key hospitals with traditional Chinese medicine characteristics, and national Chinese medicine epidemic prevention and control bases, and implement the famous doctor hall project to improve the infectious disease prevention and control capabilities of county-level Chinese medicine hospitals
.
Promote Chinese medicine hospitals to take the lead in forming medical consortia
.
Improve in line with traditional Chinese medicine Medicare payment policy features, release TCM dominant diseases
.
Promote the construction of a national comprehensive reform demonstration zone for traditional Chinese medicine
.
Before the end of September 2021, develop and implement opinions on promoting the upgrading of the TCM treatment of disease-free health projects
.
(State Administration of Traditional Chinese Medicine, National Development and Reform Commission, National Health Commission, National Medical Insurance Bureau, etc.
are responsible according to the division of responsibilities)
Hospital Hospital Hospital Chinese Medicine Chinese Medicine Chinese Medicine.
Implement major projects for the revitalization and development of traditional Chinese medicine
.
Support the creation of a number of national traditional Chinese medicine inheritance and innovation centers, traditional Chinese and Western medicine collaboration "flagship" hospitals , key hospitals with traditional Chinese medicine characteristics, and national Chinese medicine epidemic prevention and control bases, and implement the famous doctor hall project to improve the infectious disease prevention and control capabilities of county-level Chinese medicine hospitals
.
Promote Chinese medicine hospitals to take the lead in forming medical consortia
.
Improve in line with traditional Chinese medicine Medicare payment policy features, release TCM dominant diseases
.
Promote the construction of a national comprehensive reform demonstration zone for traditional Chinese medicine
.
Before the end of September 2021, develop and implement opinions on promoting the upgrading of the TCM treatment of disease-free health projects
.
(State Administration of Traditional Chinese Medicine, National Development and Reform Commission, National Health Commission, National Medical Insurance Bureau, etc.
are responsible according to the division of responsibilities)
In fact, promote the revitalization and development of traditional Chinese medicine, comprehensively improve the characteristic advantages and service capabilities of traditional Chinese medicine, meet the people's demand for traditional Chinese medicine, and focus on major chronic diseases such as cardiovascular diseases, neurological diseases, malignant tumors, metabolic diseases, and gynecology, Dominant diseases such as skin and immunity, and dominance diseases of traditional Chinese medicine such as acupuncture and other non-drug therapies have become important directions for the development of Chinese medicine during the 14th Five-Year Plan
.
.
In addition, vigorously strengthening the construction of the grassroots TCM talent team can consolidate the foundation of TCM development
.
The analysis of industry experts pointed out that the total number of TCM professionals is insufficient and the gap is large, especially for high-quality, compound and general-care personnel.
It is necessary to do a good job in the mid- and long-term planning of talent training and team building, and improve the basic level of TCM teachers.
Education and training mechanisms, rationally increase the special funding for grassroots Chinese medicine, formulate preferential policies for the introduction of talents, improve the working environment of grassroots Chinese medicine personnel, and improve the size and overall quality of the grassroots Chinese medicine talent team through various means
.
.
The analysis of industry experts pointed out that the total number of TCM professionals is insufficient and the gap is large, especially for high-quality, compound and general-care personnel.
It is necessary to do a good job in the mid- and long-term planning of talent training and team building, and improve the basic level of TCM teachers.
Education and training mechanisms, rationally increase the special funding for grassroots Chinese medicine, formulate preferential policies for the introduction of talents, improve the working environment of grassroots Chinese medicine personnel, and improve the size and overall quality of the grassroots Chinese medicine talent team through various means
.
It is understood that in the review and approval of traditional Chinese medicine and drug research and development, the State Drug Administration is cooperating with the State Drug Administration approval of the reform continue to improve the review of Chinese medicine, Chinese medicine industry to promote the development of new drug development and medicine
.
Adhere to the clinical value as the orientation, promote the establishment of efficacy evaluation standards that are compatible with the clinical positioning of traditional Chinese medicine and reflect its features and advantages, and encourage patient-centered efficacy evaluation
.
Promote the development of ancient classic famous prescriptions and traditional Chinese medicine compound preparations, organize research and formulate key information research opinions on ancient classic famous prescriptions, establish a review model compatible with the characteristics of ancient classic famous prescriptions and traditional Chinese medicine compound preparations, and simplify approval procedures
.
Medicine, medicine, medicine .
Adhere to the clinical value as the orientation, promote the establishment of efficacy evaluation standards that are compatible with the clinical positioning of traditional Chinese medicine and reflect its features and advantages, and encourage patient-centered efficacy evaluation
.
Promote the development of ancient classic famous prescriptions and traditional Chinese medicine compound preparations, organize research and formulate key information research opinions on ancient classic famous prescriptions, establish a review model compatible with the characteristics of ancient classic famous prescriptions and traditional Chinese medicine compound preparations, and simplify approval procedures
.
